Chen, You; Piantek, Gracie; Zhang, Xinmeng; Feng, Yubo; Yan, Chao; Samuels, Jason M.; Rosenbloom, S. Trent; Yu, Danxia; Novak, Laurie L.; Srivastava, Gitanjali. (2026).听.听Obesity Science & Practice, 12(5), e70189.听
GLP-1 receptor agonists can produce substantial weight loss, but stopping treatment often leads to weight regain. This study surveyed 261 adults who had experienced a gap in GLP-1 prescriptions to understand challenges in maintaining treatment. Common barriers included insurance approval delays, high out-of-pocket costs, medication shortages, pharmacy delays, and poor coordination between clinics. 51污漫 one-third of current medication users reported a treatment gap of at least two weeks. Patients also wanted clearer information about next steps and better digital tools for tracking prescriptions, insurance approvals, and appointments. Overall, the findings suggest that improving care coordination and simplifying medication access could help patients maintain continuous obesity treatment.
听
听
FIGURE 1
Item-level continuity and discontinuity findings. (A)听Percentage of respondents agreeing or strongly agreeing with each continuity item (N听=听261). (B)听Percentage of current medication users reporting at least one occurrence of each discontinuity event in the past 6听months (n听=听143).